Showing results (341-350 of 4,039) with videos related to
Sort By:
Pageof 404
Pharmacoepidemiology and Drug Safety|December 30, 2004
The use of prescribed drugs for common chronic conditions in South Africa in 1998Krisela Steyn, Debbie Bradshaw, Rosana Norman, et al.Pharmacoepidemiology and Drug Safety|January 18, 2005
Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactionsD Tony Yu, Josh F Peterson, Diane L Seger, et al.Pharmacoepidemiology and Drug Safety|January 18, 2005
Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indicationCarol E Koro, Steven J Bowlin, Sheila R WeissPharmacoepidemiology and Drug Safety|January 18, 2005
Antivirals and antibiotics for influenza in the United States, 1995--2002Jeffrey A Linder, David W Bates, Richard PlattPharmacoepidemiology and Drug Safety|June 2, 2004
Application of a propensity score to adjust for channelling bias with NSAIDsS V Morant, D Pettitt, T M MacDonald, et al.Pharmacoepidemiology and Drug Safety|June 2, 2004
Pharmacoepidemiology 101: data monitoring committees in the post-marketing approval settingDavid E LilienfeldPharmacoepidemiology and Drug Safety|August 19, 2004
A retrospective, study of prescribing for erectile dysfunction in a UK population during 1997-2000: demand was neither excessive nor continuing to riseFrank Sullivan, Louise Donnelly, Peter DonnanPharmacoepidemiology and Drug Safety|August 19, 2004
Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel diseaseRichard B Gearry, Murray L Barclay, Michael J Burt, et al.Pharmacoepidemiology and Drug Safety|June 15, 2005
Comparing data mining methods on the VAERS databaseDavid Banks, Emily Jane Woo, Dale R Burwen, et al.Pharmacoepidemiology and Drug Safety|January 11, 2005
Managing the risks of therapeutic products: proceedings of a workshopJudith M KramerPageof 404